BDBM50013202 3-[(5-Chloro-pyrazin-2-ylamino)-methyl]-5-(2-fluoro-phenyl)-1,3-dihydro-benzo[e][1,4]diazepin-2-one::CHEMBL423918

SMILES Fc1ccccc1C1=NC(CNc2cnc(Cl)cn2)C(=O)Nc2ccccc12

InChI Key InChIKey=PKPCNUPLPQWEMV-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50013202   

TargetCholecystokinin receptor type A(Rat)
Merck Sharp & Dohme Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50013202(CHEMBL423918 | 3-[(5-Chloro-pyrazin-2-ylamino)-met...)
Affinity DataIC50: 1.50E+4nMAssay Description:Inhibition of binding of [125I]CCK-8 to Cholecystokinin type A receptor in rat pancreasMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetGastrin/cholecystokinin type B receptor(Human)
Merck Sharp & Dohme Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50013202(CHEMBL423918 | 3-[(5-Chloro-pyrazin-2-ylamino)-met...)
Affinity DataIC50: 1.00E+5nMAssay Description:Inhibition of binding of [125I]CCK-8 to Cholecystokinin type B receptor in guinea pig brain tissuesMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed